DFDário Celestino Sobral Filho

Dário Celestino Sobral Filho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dário Celestino Sobral Filho has a total of 111 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Maskerading Bundle Branch Block Versus Standard Bifascicular Block: A Prognostic Analysis Results Through Electrophysiological Study

    by Afonso Luiz Tavares de Albuquerque, Caroline de Paula Coutinho Vaz de Lira, José Nilo de Carvalho Neto, Rodrigo Rufino Pereira Silva, Iremar Salviano de Macedo Neto, Dário Celestino Sobral Filho

    Background: Maskerading bundle branch block (MBBB) is a rare variant of standard bifascicular bundle branch block (SBBB), associated with poor prognosis and a higher need for pacemaker implantation. Most available data are limited to case reports and reviews. Methods: In this prospective cross‐sectional study, we evaluated 27 patients with MBBB (Group I) and 18 with SBBB (Group II), all undergoing echocardiography, 24‐h Holter monitoring, and invasive electrophysiological study (EPS) after recruitment. Results: Group I patients had worse functional status (NYHA III–IV), larger ventricular diameters, and lower ejection fraction. The HV interval was significantly longer in Group I (66.3 ± 18.3 vs. 52.9 ± 8.1 ms; p = 0.006). Pacemaker implantation was required in 48% of Group I patients versus none in Group II ( p = 0.001). Persistent atrial fibrillation was also more frequent in Group I (39.5% vs. 16.6%; p = 0.018). Conclusion: MBBB is associated with more severe myocardial and conduction system impairment compared to SBBB, supporting its role as a marker of worse prognosis.

  • Open Access

    Sex‐Specific Differences in Visceral and Subcutaneous Adiposity Accumulation and Their Association With Metabolic Abnormalities

    by Isa Galvão Rodrigues, Gabriela Maria Pereira Floro Arcoverde, Camila Lima Chagas Do Nascimento, Victoria Domingues Ferraz, Nadja Fernandes da Silva, Ilma Kruze Grande de Arruda, Cláudia Porto Sabino Pinho, Dário Celestino Sobral Filho

    Some studies suggest that body fat distribution differs between sexes; there remains a gap regarding the exact mechanisms that regulate these differences and their cardiometabolic consequences. This study investigated sex‐specific differences influencing the concentration and metabolic risk associated with visceral abdominal adipose tissue (VAT) and subcutaneous adipose tissue (SAT). This cross‐sectional study includes outpatients from a university‐affiliated public hospital. Consecutive patients aged ≥ 20 years were included in our sample. VAT and SAT were measured using ultrasound (the mean of three attempts). Intra‐ and interevaluator reproducibility was tested, demonstrating high reliability (> 0.90) for both VAT and SAT. Demographic (age, sex, and self‐reported race), anthropometric, behavioral, and biochemical variables were assessed. A total of 253 patients were included. They had a mean age of 46.3 ± 11.6 years (64.4% females and 68.7% non‐white). Although the mean total abdominal adipose tissue was similar between sexes ( p = 0.125), males exhibited a higher mean VAT (7.3 ± 3.0 vs. 6.0 ± 2.1 cm; p < 0.001), while women presented with a higher mean SAT (3.4 ± 1.2 vs. 2.7 ± 1.4 cm; p < 0.001). Among females, VAT was directly associated with serum triglycerides (TG), TG/HDL ratio, blood glucose, and glycated hemoglobin (HbA1c), and inversely associated with HDL. VAT/SAT ratio predicted higher levels of total cholesterol (TC), LDL, TG, TG/HDL ratio, glucose, and HbA1c ( p < 0.05). Among males, VAT did not significantly affect metabolic alterations. In conclusion, within the same mean BMI, males had higher VAT concentrations, whereas in females, despite lower VAT, a worse adverse metabolic profile was observed.


  • Top Cited Papers
    Open Access

    Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023

    by José Antonio Marin-Neto, Anis Rassi, Gláucia Maria Moraes Oliveira, Luís Claudio Lemos Correia, Alberto Novaes Ramos, Alejandro Ostermayer Luquetti, Alejandro Marcel Hasslocher-Moreno, Andréa Silvestre de Sousa, Angelo Amato Vincenzo de Paola, Antônio Carlos Sobral Sousa, et al.

    Lista de Siglas/Abreviaturas 18 F-FDG – fluordesoxiglicose marcado com flúor-18 123 I-MIBG – meta-iodo-benzil-guanidina marcado com iodo-123 […] Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023 Lista de Siglas/Abreviaturas 18 F-FDG – fluordesoxiglicose marcado com flúor-18 123 I-MIBG – meta-iodo-benzil-guanidina marcado com iodo-123 […] Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023


  • Open Access

    Detection of atrial fibrosis using echocardiographic strain: a new pathway

    by Maria Mariana Barros Melo da Silveira, João Victor Batista Cabral, Amanda Tavares Xavier, Lucas Reis da Costa, Dhouglas José Ferreira Do Nascimento, José Maria Del Castillo, Luydson Richardson da Silva Vasconcelos, Dário Celestino Sobral Filho, Dinaldo Cavalcanti de Oliveira